BioTime (BTX) is Initiated by Oppenheimer to Outperform, Price Target at $10

BioTime (BTX) is Initiated by Oppenheimer to Outperform according to the research report released to the investors. The brokerage firm has set the Price Target of the shares at $10. The shares recommendation by the Brokerage Firm was released on Dec-22-2015.